Donepezil in the Prevention of Post-Operative Cognitive Decline

Completed · Phase 4

Conditions studied: Postoperative Complications, Delirium

In brief

The purpose of this study is to evaluate the feasibility of using Donepezil to prevent post-operative cognitive decline (POCD) among individuals aged 65 and older who have a baseline mild cognitive impairment (MCI) and are undergoing elective hip or knee replacement.

Key facts

Study ID
NCT00182845
Run by
Pfizer
People needed
30
Starts
2005-02-01
Expected to finish
2007-04-01
Last updated by the study team
2008-03-03

Who can join

Age: 65 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.